期刊文献+

低分子肝素和普通肝素在主动脉内球囊反搏术中抗凝应用的临床观察 被引量:1

Study on the clinical effects of low molecular weight heparin and unfractionated heparin in intra-aortic balloon pump surgery
下载PDF
导出
摘要 目的:观察低分子肝素(LMWH)和普通肝素(UFH)在主动脉内球囊反搏术(IABP)中抗凝应用的临床效果。方法:68例安置IABP的患者随机分为应用UFH抗凝的常规组(34例)和应用LMWH抗凝的试药组(34例),观察两组患者的出血、血肿、血栓形成等并发症发生情况及费用差别。结果:两组均只有少部分患者有伤口少量渗血、局部小血肿和伤口周围轻度青紫等表现,无其它并发症出现,两组比较差异无显著性。但试药组的费用比常规组低,两组比较差异有显著性。结论:在IABP中应用LMWH可以达到应用UFH相同的抗凝、预防血栓形成的效果,同时并发症无增加,而费用减少。 AIM : To observe the clinical effect of low molecular weight heparin (LMWH) compared with unfractionated heparin (UFH) in intra-aortic balloon pump (IABP) surgery. METHODS: Sixty-eight patients with IABP were randomly divided into two groups: conventional group (34 cases) using UFH anticoagulation and observation group (34 cases) using LMWH anticoagulation. The incidence of bleeding, hematoma, thrombosis and other complications, as well as the cost in the two groups, were recorded. RESULTS : Only slight wound bleeding, local small hematoma and mild bruising around the wound were observed in a low percentage of the patients, with no significant difference between groups. However, the cost in the observation group was significantly lower than in the conventional group. CONCLUSION: LMWH has a low cost and is more convenient and if as effective as UFH in regard to anticoagulant and antithrombotic effect for IABP
出处 《心脏杂志》 CAS 2012年第5期620-621,共2页 Chinese Heart Journal
关键词 低分子肝素 主动脉 球囊反搏术 low molecular weight heparin aorta balloon pump surgery
  • 相关文献

参考文献6

二级参考文献54

  • 1龙健,曾智.低分子肝素对血管内皮细胞舒缩功能的影响[J].心脏杂志,2004,16(4):295-296. 被引量:14
  • 2汪昱,郑起,闫钧,汤钊猷.低分子肝素对肝癌生长和转移抑制作用的研究[J].中华普通外科杂志,2004,19(12):758-760. 被引量:11
  • 3张晓玲,陈方,高阅春,吴长燕,李铮.低分子肝素在经皮冠状动脉成形术中的应用[J].中国介入心脏病学杂志,2005,13(1):23-24. 被引量:7
  • 4朱建华,邱原刚,陈君柱,张芙荣,傅国胜,沈法荣,黄伟剑,王建安,赵莉莉,陶谦民,郑良荣.经皮冠状动脉介入治疗中静脉注射那屈肝素的抗血栓疗效及安全性评价[J].中华心血管病杂志,2005,33(4):335-339. 被引量:6
  • 5Bobek V, Kovarvk J. Antitumor and antimetastatic effect of warfarin and heparin[J]. Biomed Pharmacother, 2004, 58:213-219.
  • 6Abdel-Salam OM, Baiuomy AR, Ameen A, et al. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat [J]. Pharmacol Res, 2005,51: 59-67.
  • 7Arikan S, Adas G, Barut G, et al. An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra-abdominal adhesions and wound healing [J]. Am J Surg, 2005, 189: 155-160.
  • 8Deepa PR, Varalakshmi P. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis [J]. Clin Chim Acta, 2004, 339: 105-115.
  • 9Sundaram M, Qi Y, Shriver Z, et al. Rational design of low-molecular weight heparins with improved in vivo activity[J]. PNAS, 2003, 100: 651-656.
  • 10Pross M, Lippert H, Nestler G, et al. Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study [J]. lnt J Colorectal Dis,2004, 19: 143-146.

共引文献53

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部